1. Home
  2. AFRM vs NTRA Comparison

AFRM vs NTRA Comparison

Compare AFRM & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFRM
  • NTRA
  • Stock Information
  • Founded
  • AFRM 2012
  • NTRA 2003
  • Country
  • AFRM United States
  • NTRA United States
  • Employees
  • AFRM N/A
  • NTRA N/A
  • Industry
  • AFRM Business Services
  • NTRA Medical Specialities
  • Sector
  • AFRM Consumer Discretionary
  • NTRA Health Care
  • Exchange
  • AFRM Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • AFRM 21.3B
  • NTRA 21.7B
  • IPO Year
  • AFRM 2021
  • NTRA 2015
  • Fundamental
  • Price
  • AFRM $87.35
  • NTRA $168.02
  • Analyst Decision
  • AFRM Buy
  • NTRA Strong Buy
  • Analyst Count
  • AFRM 26
  • NTRA 16
  • Target Price
  • AFRM $79.86
  • NTRA $193.50
  • AVG Volume (30 Days)
  • AFRM 9.8M
  • NTRA 1.2M
  • Earning Date
  • AFRM 11-06-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • AFRM N/A
  • NTRA N/A
  • EPS Growth
  • AFRM N/A
  • NTRA N/A
  • EPS
  • AFRM 0.15
  • NTRA N/A
  • Revenue
  • AFRM $3,224,412,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • AFRM $22.56
  • NTRA $23.93
  • Revenue Next Year
  • AFRM $22.65
  • NTRA $15.60
  • P/E Ratio
  • AFRM $545.08
  • NTRA N/A
  • Revenue Growth
  • AFRM 38.80
  • NTRA 44.38
  • 52 Week Low
  • AFRM $30.90
  • NTRA $110.57
  • 52 Week High
  • AFRM $100.00
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • AFRM 62.90
  • NTRA 62.59
  • Support Level
  • AFRM $81.60
  • NTRA $156.71
  • Resistance Level
  • AFRM $100.00
  • NTRA $170.72
  • Average True Range (ATR)
  • AFRM 4.61
  • NTRA 4.62
  • MACD
  • AFRM 0.82
  • NTRA 0.39
  • Stochastic Oscillator
  • AFRM 56.77
  • NTRA 80.73

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: